Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Glutathione has been nicknamed the "master antioxidant," but some people are buying it online and self-injecting it, which ...

Global small molecule API market will reach $360.0 billion by 2032, growing by 7.0% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...